China Literature Limited (HKG:0772)

Theseus Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	31,429	25,595	29,730	30,762	50,079	61,810
Market Cap Growth	-13.91%	-13.91%	-3.36%	-38.57%	-18.98%	87.87%
Enterprise Value	23,495	18,279	22,360	23,368	43,349	56,999
Last Close Price	30.78	25.20	29.05	30.30	49.00	60.85
PE Ratio	-	-	33.53	44.74	22.09	-
Forward PE	21.30	15.76	16.39	17.50	24.72	44.73
PS Ratio	3.64	2.96	3.85	3.57	4.71	6.11
PB Ratio	1.61	1.31	1.42	1.52	2.37	3.45
P/TBV Ratio	2.42	1.97	2.31	2.58	4.19	7.02
P/FCF Ratio	11.76	9.58	24.68	18.39	37.31	47.90
P/OCF Ratio	11.69	9.52	23.85	17.26	36.48	46.88
PEG Ratio	-	0.53	0.53	0.53	0.81	1.79
EV/Sales Ratio	2.72	2.12	2.90	2.71	4.07	5.63
EV/EBITDA Ratio	18.60	19.60	20.14	17.74	31.66	45.09
EV/EBIT Ratio	23.80	24.94	25.41	23.26	50.06	57.93
EV/FCF Ratio	8.79	6.84	18.56	13.97	32.30	44.17
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0.08	0.09
Debt / EBITDA Ratio	0.18	0.18	0.22	0.49	1.21	1.18
Debt / FCF Ratio	0.07	0.07	0.22	0.42	1.33	1.23
Asset Turnover	0.35	0.35	0.31	0.33	0.39	0.36
Inventory Turnover	5.75	5.75	4.73	5.09	6.64	7.29
Quick Ratio	2.29	2.29	2.56	2.61	2.34	2.34
Current Ratio	2.65	2.65	3.12	3.13	2.82	2.73
Return on Equity (ROE)	-1.12%	-1.12%	4.35%	3.46%	11.42%	-26.08%
Return on Assets (ROA)	1.87%	1.87%	2.17%	2.41%	1.98%	2.18%
Return on Capital (ROIC)	2.28%	2.28%	2.64%	2.99%	2.51%	2.78%
Return on Capital Employed (ROCE)	3.70%	3.70%	4.10%	4.70%	3.80%	4.80%
Earnings Yield	-0.71%	-0.87%	2.98%	2.23%	4.53%	-8.62%
FCF Yield	8.50%	10.44%	4.05%	5.44%	2.68%	2.09%
Buyback Yield / Dilution	0.54%	0.54%	0.14%	-0.26%	-1.70%	0.79%

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.